Filtros : "Tailândia" "Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)" Removido: "Japão" Limpar

Filtros



Refine with date range


  • Source: Asian Pacific Journal of Cancer Prevention. Unidade: FMRP

    Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, LINHAGEM CELULAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUARTE, Andressa et al. The role of the LY294002: a non-selective inhibitor of phosphatidylinositol 3-kinase (PI3K) pathway- in cell survival and proliferation in cell line SCC-25. Asian Pacific Journal of Cancer Prevention, v. 20, n. 11, p. 3377-3383, 2019Tradução . . Disponível em: https://doi.org/10.31557/APJCP.2019.20.11.3377. Acesso em: 09 jun. 2024.
    • APA

      Duarte, A., Silveira, G. G. da, Soave, D. F., Costa, J. P. O. da, & Ribeiro-Silva, A. (2019). The role of the LY294002: a non-selective inhibitor of phosphatidylinositol 3-kinase (PI3K) pathway- in cell survival and proliferation in cell line SCC-25. Asian Pacific Journal of Cancer Prevention, 20( 11), 3377-3383. doi:10.31557/APJCP.2019.20.11.3377
    • NLM

      Duarte A, Silveira GG da, Soave DF, Costa JPO da, Ribeiro-Silva A. The role of the LY294002: a non-selective inhibitor of phosphatidylinositol 3-kinase (PI3K) pathway- in cell survival and proliferation in cell line SCC-25 [Internet]. Asian Pacific Journal of Cancer Prevention. 2019 ; 20( 11): 3377-3383.[citado 2024 jun. 09 ] Available from: https://doi.org/10.31557/APJCP.2019.20.11.3377
    • Vancouver

      Duarte A, Silveira GG da, Soave DF, Costa JPO da, Ribeiro-Silva A. The role of the LY294002: a non-selective inhibitor of phosphatidylinositol 3-kinase (PI3K) pathway- in cell survival and proliferation in cell line SCC-25 [Internet]. Asian Pacific Journal of Cancer Prevention. 2019 ; 20( 11): 3377-3383.[citado 2024 jun. 09 ] Available from: https://doi.org/10.31557/APJCP.2019.20.11.3377

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024